Grant: Project Grant
University of British Columbia
$1,095,100.00
Precision Diagnosis and Management of Cardiogenetics: The Hearts in Rhythm Organization (HiRO)
FY 2025-26
Summary
The Hearts in Rhythm Organization (HiRO) is pioneering a groundbreaking approach to understanding and managing inherited heart conditions. With a national network of 25 clinics and data from 6,855 patients and family members, HiRO aims to transform how we diagnose and treat uncommon cardiac genetic disorders.
Working together with researchers, patients and their family members, and healthcare professionals, HiRO aims to improve and standardize care in Canada. The research team oversees national registries, which include large repositories of patient data, including 21,369 ECGs, 7,311 stress tests, and 6,685 echocardiograms.
In this project, we aim to: 1) Develop an artificial intelligence (AI) platform to improve diagnostic accuracy; 2) Create risk prediction tools for inherited heart conditions; 3) Design a patient dashboard to support clinical decision-making.
Combining ECG digital signals, imaging data, genetic sequencing, and anonymized clinical records, we will develop AI-driven diagnostic models. Our AI-platform will predict diagnoses for conditions, such as Long QT Syndrome, Brugada Syndrome, and Arrhythmogenic Cardiomyopathy. All information will be integrated to create patient dashboards with personalized clinical summaries, risk calculators (e.g., five-year sudden cardiac death risk), and insights to guide clinical decision-making.
We expect that our AI platform will improve diagnostic certainty and provide more accurate risk assessment, enabling personalized patient care. Development and use of the platform will enhance our understanding of rare cardiac genetic conditions so that we can develop better treatment strategies for the future.
Our team of experts in cardiac genetics and AI is uniquely positioned to carry out this work. This project represents a significant step towards precision medicine in cardiac genetics, leveraging advanced analytics based on AI to transform patient care and risk management.
Department
Program
Project Grant
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
564672
Name
Krahn Andrew D
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Clinical Investigation - D: Cardiovascular Systems
Projecttitle
Precision Diagnosis and Management of Cardiogenetics: The Hearts in Rhythm Organization (HiRO)
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$1,095,100
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Artificial Intelligence; Diagnosis; Genetics; Inherited Cardiac Conditions; Polygenic Risk Score; Precision Medicine; Registry; Risk Management
Abstract
The Hearts in Rhythm Organization (HiRO) is pioneering a groundbreaking approach to understanding and managing inherited heart conditions. With a national network of 25 clinics and data from 6,855 patients and family members, HiRO aims to transform how we diagnose and treat uncommon cardiac genetic disorders.
Working together with researchers, patients and their family members, and healthcare professionals, HiRO aims to improve and standardize care in Canada. The research team oversees national registries, which include large repositories of patient data, including 21,369 ECGs, 7,311 stress tests, and 6,685 echocardiograms.
In this project, we aim to: 1) Develop an artificial intelligence (AI) platform to improve diagnostic accuracy; 2) Create risk prediction tools for inherited heart conditions; 3) Design a patient dashboard to support clinical decision-making.
Combining ECG digital signals, imaging data, genetic sequencing, and anonymized clinical records, we will develop AI-driven diagnostic models. Our AI-platform will predict diagnoses for conditions, such as Long QT Syndrome, Brugada Syndrome, and Arrhythmogenic Cardiomyopathy. All information will be integrated to create patient dashboards with personalized clinical summaries, risk calculators (e.g., five-year sudden cardiac death risk), and insights to guide clinical decision-making.
We expect that our AI platform will improve diagnostic certainty and provide more accurate risk assessment, enabling personalized patient care. Development and use of the platform will enhance our understanding of rare cardiac genetic conditions so that we can develop better treatment strategies for the future.
Our team of experts in cardiac genetics and AI is uniquely positioned to carry out this work. This project represents a significant step towards precision medicine in cardiac genetics, leveraging advanced analytics based on AI to transform patient care and risk management.
Competitiondate
202603
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Krahn, Andrew D
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $1,095,100~ $0~